MedTrace Logo

Hormone Replacement Therapy After Risk Reducing Salpingo-oophorectomy

NCT06972719 · Status: RECRUITING · Phase: NA · Type: INTERVENTIONAL · Enrollment: 50

Last updated 2026-03-27

No results posted yet for this study

Summary

The goal of this study is to develop an educational aid about hormone replacement therapy that physicians can share with patients as part of their pre-surgical counseling for a risk-reducing salpingo-oophorectomy (RRSO).

Conditions

  • BRCA1 Mutation
  • BRCA2 Mutation

Interventions

BEHAVIORAL

Experimental Arm

Participants will be randomized to SOC plus the video.

BEHAVIORAL

SOC Arm

Participants will be randomized to SOC counseling.

Sponsors & Collaborators

Principal Investigators

  • Laura Havrilesky · Duke University

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
19 Years
Max Age
50 Years
Sex
FEMALE
Healthy Volunteers
No

Timeline & Regulatory

Start
2025-09-30
Primary Completion
2026-07-01
Completion
2026-12-31

Countries

  • United States

Study Locations

More Related Trials

Entities

Companies

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06972719 on ClinicalTrials.gov